DFNA5 Polyclonal Antibody
Product Specifications
Background
DFNA5, deafness associated tumor suppressor (DFNA5) Homo sapiens Hearing impairment is a heterogeneous condition with over 40 loci described. The protein encoded by this gene is expressed in fetal cochlea, however, its function is not known. Nonsyndromic hearing impairment is associated with a mutation in this gene. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Product Name Alternative
DFNA5; ICERE1; Non-syndromic hearing impairment protein 5; Inversely correlated with estrogen receptor expression 1; ICERE-1
Gene ID
1687
Swiss Prot
O60443
Cross Reactivity
Human; Rat
Clonality
Polyclonal
Source
Rabbit
Applications
WB; ELISA
Dilution
Western Blot: 1/500 - 1/2000. ELISA: 1/40000. Not yet tested in other applications.
Buffer
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Molecular Weight
54
Storage Conditions
-20°C/1 year
Protein Weight
54
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
OR1060187-01 100 mg
2-Chloro-5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) thiazole
Sign In for Pricing
View Details OR1060187-02 250 mg
2-Chloro-5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) thiazole
Sign In for Pricing
View Details OR1060187-03 1 g
2-Chloro-5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) thiazole
Sign In for Pricing
View Details 